Joseph A. DiGiuseppe
机构: Director of Hematopathology, Hartford Hospital
每年引用次数
引用次数
引用: 8,537
H-指数: 36
I10-指数 : 54
出版物: 115
Blastic natural killer-cell leukemia/lymphoma (NKL/L): A clinicopathologic study of 3 cases
JA DiGiuseppe , DC Louie , JE Williams , DT Miller
LABORATORY INVESTIGATION 76 ( 1) 718 -718
1997
Growth factor modulation of p21 (WAF1/CIP1) in primary acute myeloid leukemias.
JA DiGiuseppe , SD Gore , LJ Weng , MB Kastan
BLOOD 88 ( 10) 331 -331
1996
Hepatosplenic and subcutaneous gamma delta T-cell lymphomas are preferentially derived from different gamma delta T-cell subsets.
H Wu , GK Przybylski , DGB Leonard , MA Wasik
MODERN PATHOLOGY 11 ( 1) 142A -142A
1998
Acute lymphoblastic leukemia
MJ Borowitz , JA DiGiuseppe
Neoplastic hematopathology. Philadelphia. Lippincott Williams & Wilkins 1643 -66
29
2001
Clinical applications of flow cytometric immunophenotyping in acute lymphoblastic leukemia
JA DiGiuseppe , MJ Borowitz
Immunophenotyping. New York; John Wiley & Sons Inc 161 -180
5
2000
Laboratory evaluation of hypercoagulable states
JA DiGiuseppe , MH Kroll
Clinical Laboratory News 8 -13
3
1995
Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: efficiency of minimal residual disease (MRD) detection by flow cytometric immunophenotyping compared with commonly used markers
H Shinoda-Matsuoka , JA DiGiuseppe
LABORATORY INVESTIGATION 89 388A -388A
2
2009
Clinical validation of two PCR-based assays for detection of the JAK2V617F mutation in non-CML chronic myeloproliferative disorders
MS Clark , SG Fuller , JA DiGiuseppe
LABORATORY INVESTIGATION 86 326A -326A
2006
Unique pattern of TdT immunofluorescence distinguishes normal precursor B cells (hematogones) from acute lymphoblastic leukemia
MT Hurford , H Dinep , AJ Altman , JA DiGiuseppe
LABORATORY INVESTIGATION 81 ( 1) 233A -233A
2001
TIA-1 is expressed in normal and neoplastic myeloid cells
C Marshall-Taylor , D Mandich , JA DiGiuseppe
LABORATORY INVESTIGATION 81 ( 1) 172A -172A
2001
CD38 expression is associated with atypical morphology and immunophenotype in B-cell chronic lymphocytic leukemia.
PUF Shen , SJ Fuller , WN Rezuke , BJ Sherburne
LABORATORY INVESTIGATION 81 ( 1) 178A -178A
2001
Copper deficiency as a cause of reversible anemia and neutropenia.
Saad Usmani , Susan Tannenbaum , Nicola Jabbour , Joseph A DiGiuseppe
Connecticut medicine 74 ( 5) 261
4
2010
K-ras mutations in pancreatic ductal proliferative lesions
Ralph H Hruban , Joseph A DiGiuseppe , G Johan A Offerhaus
The American Journal of Pathology 145 ( 6) 1548 -1548
7
1994
Body Size, Physical Activity, and Risk of Hodgkin's Lymphoma in Women
Theresa HM Keegan , Sally L Glaser , Christina A Clarke , Ronald F Dorfman
Cancer Epidemiology, Biomarkers & Prevention 15 ( 6) 1095 -1101
26
2006
Risk Stratification of Additional Chromosomal Changes in Chronic Myelogenous Leukemia in Era of Tyrosine Kinase Inhibitor Therapy
Wei Wang , Jorge Cortes , Guilin Tang , Joseph D Khoury
LABORATORY INVESTIGATION 96 382A -383A
2016
Annual ICCS Meeting Plenary Session Reports
Joseph A DiGiuseppe ,
Leukemias and lymphomas
Joseph A DiGiuseppe , Michael J Borowitz
Tumor markers 321 -328
2
2002
A QA program for MRD testing demonstrates that systematic education can reduce discordance among experienced interpreters
Michael Keeney , Brent L Wood , Benjamin D Hedley , Joseph A DiGiuseppe
Cytometry Part B: Clinical Cytometry
36
2017
Acute lymphoblastic leukemia/lymphoma: Diagnosis and minimal residual disease detection by flow cytometric immunophenotyping
Joseph A DiGiuseppe
Manual of molecular and clinical laboratory immunology 207 -216
8
2016
Immunophenotyping of acute lymphoblastic leukemia
Joseph A DiGiuseppe , Jolene L Cardinali
Immunophenotyping: Methods and Protocols 297 -310
5
2019